Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CN128 Tablets in Transfusion-Dependent Thalassemia With Iron Overload
CTR20201051Phase 2Completed
- Sponsor
- Hangzhou Zede Pharmaceutical Technology
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tiralos in Thalassaemia, iron overload, sponsored by Hangzhou Zede Pharmaceutical Technology. Started Sep 2020; status: completed.
02
Drugs
Tiralos
03
Conditions
Thalassaemiairon overload
Beyond the preview
Go deeper on CTR20201051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201051.